ArticleClinical drug investigation2024

Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study.

Gianni Carraro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.